MP488DAILY EXIT-SITE AND INTRANASAL MUPIROCIN IN ALL PD PATIENTS TO PREVENT STAPHYLOCOCCUS AUREUS PERITONITIS: A MORE EFFECTIVE APPROACH THAN MONTHLY INTRANASAL MUPIROCIN IN STAPHYLOCOCCUS AUREUS CARRIERS ONLY
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI